These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11848213)

  • 1. Release from or through a wax matrix system. II. Basic properties of release from or through the wax matrix layer.
    Yonezawa Y; Ishida S; Suzuki S; Sunada H
    Chem Pharm Bull (Tokyo); 2002 Feb; 50(2):220-4. PubMed ID: 11848213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release from or through a wax matrix system. III. Basic properties of release through the wax matrix layer.
    Yonezawa Y; Ishida S; Suzuki S; Sunada H
    Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):814-7. PubMed ID: 12045337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release from or through a wax matrix system. IV. Generalized expression of the release process for a reservoir device tablet.
    Yonezawa Y; Ishida S; Suzuki S; Sunada H
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1219-22. PubMed ID: 12237539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release from or through a wax matrix system. I. Basic release properties of the wax matrix system.
    Yonezawa Y; Ishida S; Sunada H
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1448-51. PubMed ID: 11724236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release from or through a wax matrix system. V. Applicability of the square-root time law equation for release from a wax matrix tablet.
    Yonezawa Y; Ishida S; Sunada H
    Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):904-8. PubMed ID: 12913226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release from or through a wax matrix system. VI. Analysis and prediction of the entire release process of the wax matrix tablet.
    Yonezawa Y; Ishida S; Sunada H
    Chem Pharm Bull (Tokyo); 2005 Aug; 53(8):915-8. PubMed ID: 16079519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmable drug release of highly water-soluble pentoxifylline from dry-coated wax matrix tablets.
    Otsuka M; Matsuda Y
    J Pharm Sci; 1995 Apr; 84(4):443-7. PubMed ID: 7629734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of pH Modulation on Dynamic Behavior of Gel Layer and Release of Weakly Basic Drug from HPMC/Wax Matrices, Controlled by Acidic Modifiers Evaluated by Multivariate Data Analysis.
    Mašková E; Kubová K; Vysloužil J; Pavloková S; Vetchý D
    AAPS PharmSciTech; 2017 May; 18(4):1242-1253. PubMed ID: 27474035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of internal structure on kinetics of drug release from wax matrix tablets.
    Ishino R; Yoshino H; Hirikawa Y; Noda K
    Chem Pharm Bull (Tokyo); 1990 Dec; 38(12):3440-5. PubMed ID: 2092942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-controlled pulse-drug release from dry-coated wax matrix tablets for colon drug delivery.
    Peerapattana J; Otsuka K; Otsuka M
    Biomed Mater Eng; 2004; 14(3):293-301. PubMed ID: 15299241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix.
    Perez MA; Ghaly ES; Marti A
    P R Health Sci J; 1993 Dec; 12(4):263-7. PubMed ID: 8140204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of processing methods and heat treatment on the formation of wax matrix tablets for sustained drug release.
    Zhang YE; Tchao R; Schwartz JB
    Pharm Dev Technol; 2001; 6(2):131-44. PubMed ID: 11416986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-Layered Matrix of Shellac Wax-Lutrol in Controlled Dual Drug Release.
    Phaechamud T; Choncheewa CE
    AAPS PharmSciTech; 2016 Dec; 17(6):1326-1335. PubMed ID: 26694059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of gastroretentive sustained release tablets prepared by combination of melt/sublimation actions of L-menthol and penetration of molten polymers into tablets.
    Fukuda M; Goto A
    Chem Pharm Bull (Tokyo); 2011; 59(10):1221-6. PubMed ID: 21963630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnauba wax as a promising excipient in melt granulation targeting the preparation of mini-tablets for sustained release of highly soluble drugs.
    Nart V; Beringhs AO; França MT; de Espíndola B; Pezzini BR; Stulzer HK
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):250-257. PubMed ID: 27770888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of controlled release system with multi-layers of powder.
    Shimono N; Ueda M; Nakamura Y
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1169-75. PubMed ID: 12237531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-unit dosage formulations of theophylline for controlled release applications.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2007; 64(6):553-9. PubMed ID: 18323251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of hydrophobic materials as matrices for controlled-release drug delivery.
    Quadir MA; Rahman MS; Karim MZ; Akter S; Awkat MT; Reza MS
    Pak J Pharm Sci; 2003 Jul; 16(2):17-28. PubMed ID: 16414573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the compressibility of wax matrix granules of acetaminophen and their admixtures with various tableting bases.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2006 Apr; 19(2):103-7. PubMed ID: 16751119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.